8.00% Nts 08/01/30 (PL39)

We're talking about OTC. NASDAQ already pushed NWBO out.

One of these days you will be right.

Clearly no "valid clinical design" as FDA wasn't buying it. Just watch, NWBO won't apply for U.S. approval until they do another trial. P3 trial was manipulated.

I remember about 10 years ago there was a job posting for a job relating to stock market compliance, don't remember the title exactly, and we all got excited. Well, 10 years has passed.

Get money my g Im pulling for you, I hope this gem of gems come through for you.

Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2026July 6, 2026 9:57 PM
Business WireMitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -37 (Extreme Bearish). Extreme Overdue: 60 min (60-E-1,60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/6/ipnir1_Status_Report.PNG

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -37 (Extreme Bearish). Extreme Overdue: 60 min (60-E-1,60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/6/ipnir1_Status_Report.PNG

It is a good position to be in from a cost standpoint. The key to maximizing our gross margin is to articulate our value proposition on a total cost of ownership basis vs our incumbent competition. We don’t need to dramatically undercut the competition. If our power savings saves the customer $10, t

Lawyers for large companies happen all the time regular sop

Meanwhile I really like the future of this company.

JHD

Percentage of Shares Shorted
2.73% of the float of CytoDyn has been sold short.
Short Interest Ratio / Days to Cover
CytoDyn has a short interest ratio ("days to cover") of 12.25

Everyone save back a little extra cash and pile on for the moment the news hits that

LP’s dream

Be sure to mention to Moss if you’re a shareholder.

82 cents to 36 cents.

Probably because 95% of all press releases are BS. Fahman has never produced anything other than shares to sell. 

Report #9 SPX Cycles 12 Month Range Forecast: New high for the month,
The projected high range is based on the current year 60 min cycle average.
The projected low range is based on the 60 min cycle averages from 2011 to present

https://investorshub.advfn.com/uimage/uplo

.001 come very soon

Report #9 SPX Cycles 12 Month Range Forecast: New high for the month,
The projected high range is based on the current year 60 min cycle average.
The projected low range is based on the 60 min cycle averages from 2011 to present

https://investorshub.advfn.com/uimage/uplo

Classic affinity scam.

For us it will be business as usual 😄

https://fanniemae.wd1.myworkdayjobs.com/FannieMaeCareers/job/Washington-DC/Deputy-General-Counsel-for-Regulatory-Compliance-and-Strategy_JR2561

So I saw this, this weekend and thought it was interesting. Fannie is looking for an attorney regarding regulatory and compliance. Like I h

Can you do a cop paste. Can't seem to open link

dont like it